Prescription Refills during an Emergency

Similar documents
Understanding the STOP Act s 5- and 7-day prescribing limits

HOW DOES THE STOP ACT IMPACT YOU?

PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R137-14

CHAPTER 206, Laws of 1981

International Narcotics Control Board

21 USC 812. NB: This unofficial compilation of the U.S. Code is current as of Jan. 4, 2012 (see

International Narcotics Control Board

Title 17-A: MAINE CRIMINAL CODE

International Narcotics Control Board QUARTERLY STATISTICS OF IMPORTS AND EXPORTS OF NARCOTIC DRUGS

Have approved and decreed: Chapter 1 Definitions

APPENDIX A FIRST SCHEDULE PSYCHOTROPIC SUBSTANCES

H 8313 S T A T E O F R H O D E I S L A N D

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled

As Introduced. 132nd General Assembly Regular Session H. B. No Representative Ramos Cosponsors: Representatives Seitz, Fedor, Ashford

(A) A practitioner or by the practitioner's authorized agent in the practitioner's presence; or

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled

Schedule II Controlled Substances

SECTION PRESCRIPTIONS

IC ARTICLE 48. CONTROLLED SUBSTANCES

SUBCHAPTER 26F CONTROLLED SUBSTANCES SECTION SCHEDULES OF CONTROLLED SUBSTANCES

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

NACRS ED reporting for opioid overdose

PART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)

Proposed Changes to Existing Measure for HEDIS : Use of Opioids at High Dosage (UOD)

The International Drug Control Conventions

MINISTRY OF HEALTH. THE CRIM INAL JUSTICE (INTERNATIONAL SI. No. 110 of 2000 CO-OPERATION) ACT, (No.42 of 2000)

Notes: Notas: Notes: Part four presents the statistical information on narcotic drugs furnished to the Board by countries and territories.

1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

SCHEDULES OF CONTROLLED SUBSTANCES

Morphine Pethidine Sufentanil 22 Anguilla Codeine 500 Fentanyl 1 Morphine 20 Pethidine 300 Remifentanil 1 Antigua and Barbuda* Cocaine 9

See Important Reminder at the end of this policy for important regulatory and legal information.

Clinical Policy: Opioid Analgesics Reference Number: OH.PHAR.PPA.13 Effective Date: 10/2017 Last Review Date: 6/2018 Line of Business: Medicaid

See Important Reminder at the end of this policy for important regulatory and legal information.

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

TRAINING MATERIAL 1961 SINGLE CONVENTION ON NARCOTIC DRUGS THE STATISTICAL RETURNS SYSTEM FOR NARCOTIC DRUGS

CLINICAL POLICY DEPARTMENT: Medical

PRESCRIPTION DRUG MONITORING PROGRAM

PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

MINISTRY OFtlISAI,TH

Appendix 3: Taking controlled and prescription drugs to other countries

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018

Dear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good

2016 Dr. Douglas H. Kay CPE Symposium

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

Iowa District Court Polk County, Iowa. CARL OLSEN, ) ) Petitioner, ) ) vs. ) ) Docket No. CV IOWA BOARD OF PHARMACY ) ) Respondent.

ARKANSAS DEPARTMENT OF HEALTH

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

APPENDIX A DRUG AND ALCOHOL TESTING POLICY AND PROCEDURES

User Guide for Transition to the Drug Information System

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

SUPPLY OF OPIATE RAW MATERIALS AND DEMAND FOR OPIATES FOR MEDICAL AND SCIENTIFIC PURPOSES

A Bill Regular Session, 2015 SENATE BILL 717

USE OF OPIODS AT HIGHER DOSES IN PERSONS WITHOUT CANCER: MORPHINE EQUIVALENT DOSE EDIT

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017

7/17/2017. FSHP 2017 ANNUAL MEETING Nothing to disclose. Opioid Overuse: National Epidemic. Opioid Epidemic: CDC Data

ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

MARYLAND BOARD OF PHARMACY

Recent Developments in FRA s Post-Accident Toxicological Testing Program

ANNUAL REPORT

Opioid Management of Chronic (Non- Cancer) Pain

Prescription Opioids

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System

Laboratory Service Report

Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM. Preventative Education: Substance Use Disorder

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

From Wikipedia, the free encyclopedia

1. Carrying Personal Medications into Thailand A. Medications containing narcotic drugs of category 2

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

North Dakota Board of Pharmacy

Opioid Pain Contracts: A Resident Driven Quality Improvement Project

CHAPTER 11. Controlled Substances SUBCHAPTER I. General Provisions SUBCHAPTER II. Standards and Schedules

Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.

Florida A & M University Office of Human Resources INTERNAL OPERATING PROCEDURE. Procedure No. HR-7000

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Lesson 5 - Regulations and Standards Assignment Answer Key

Technician Tutorial: Scheduled Drugs

Sub. S.B. 119 As Passed by the Senate

European Legal Database on Drugs

Student Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999

TEXAS COMPASSIONATE-USE ACT

See Important Reminder at the end of this policy for important regulatory and legal information.

Opioid Epidemic Update

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

45TH LEGISLATURE - STATE OF NEW MEXICO - FIRST SESSION, 2001

Minister of Social Affairs. Passed No. 73 RTL 2005, 57, 807 Entry into force

DOUGLAS COUNTY GOVERNMENT POLICY FORM. To ensure a drug-free work environment within Douglas County Government.

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

1. UNLAWFUL MANUFACTURING, IMPORTING, EXPORTING, TRAFFICKING, OR POSSESSION; CONTINUING CRIMINAL ENTERPRISE

Schedules of Controlled Substances: Temporary Placement of Furanyl Fentanyl. AGENCY: Drug Enforcement Administration, Department of Justice

PRESCRIBING GUIDELINES

Executive Summary: Licit Schedule II Drug Use and Commercial Motor Vehicle Driver Safety. October 21, 2006

Transcription:

Prescription Refills during an Emergency Many people depend on prescription medications as part of their daily routine. During an emergency, routines are frequently interrupted and people often face unusually stressful situations. Following these simple steps may help ease some of the stress and allow prescription medication users to increase their chances of survivability. These steps generally apply to non-controlled medications. Special arrangements must be made to refill a prescription listed as a Schedule II controlled substance. A list of laws, rules and regulations is attached for reference. Have the name, address, phone number, and picture identification of the prescription user If possible, have the prescribing health professional s prescription (the scrip ) Have the bottle in which the prescription was last filled, which will include the name, address and phone number of the pharmacy that filled that prescription Have the name, address and phone number of the prescribing health care professional If the prescription is a Schedule II controlled substance, the pharmacy will need to contact the prescribing physician Have the name, address and phone number of the insurance provider (if appropriate) Next is a compilation of rules, regulations and statutes.

Chapter 465, Florida Statutes 465.0275 Emergency prescription refill.--in the event a pharmacist receives a request for a prescription refill and the pharmacist is unable to readily obtain refill authorization from the prescriber, the pharmacist may dispense a one-time emergency refill of up to a 72-hour supply of the prescribed medication, with the exception of those areas or counties included in an emergency order or proclamation of a state of emergency declared by the Governor, in which the executive order may authorize the pharmacist to dispense up to a 30-day supply, providing that: (1) The prescription is not for a medicinal drug listed in Schedule II appearing in chapter 893. (2) The medication is essential to the maintenance of life or to the continuation of therapy in a chronic condition. (3) In the pharmacist's professional judgment, the interruption of therapy might reasonably produce undesirable health consequences or may cause physical or mental discomfort. (4) The dispensing pharmacist creates a written order containing all of the prescription information required by this chapter and chapters 499 and 893 and signs that order. (5) The dispensing pharmacist notifies the prescriber of the emergency dispensing within a reasonable time after such dispensing.

Florida Executive Order 08-170 Threat of Tropical Storm Fay D. In accordance with 465.0275, Florida Statutes, any pharmacist in the areas or counties covered under this Executive Order are authorized to dispense up to a 30-day emergency prescription refill. This is typical language in an executive order triggering the emergency refill stipulation. Chapter 64B16-27, Florida Administrative Code Rule 64B16-27.211, F.A.C Prescription Refills- No prescription may be filled or refilled in excess of one (1) year from the date of the original prescription was written. No prescription for a controlled substances listed in Schedule II may be refilled. No prescription for a controlled substance listed in Schedules III, IV, or V may be filled or refilled more than five (5) times within a period of six) months after the date on which the prescription was written.

Federal Rules Title 21 Code of Federal Regulations Part 1306.12 Refilling prescriptions; Issuance of multiple prescriptions. (a) The refilling of a prescription for a controlled substance listed in Schedule II is prohibited. (b)(1) An individual practitioner may issue multiple prescriptions authorizing the patient to receive a total of up to a 90-day supply of a Schedule II controlled substance provided the following conditions are met: (i) Each separate prescription is issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice; (ii) The individual practitioner provides written instructions on each prescription (other than the first prescription, if the prescribing practitioner intends for that prescription to be filled immediately) indicating the earliest date on which a pharmacy may fill each prescription; (iii) The individual practitioner concludes that providing the patient with multiple prescriptions in this manner does not create an undue risk of diversion or abuse; (iv) The issuance of multiple prescriptions as described in this section is permissible under the applicable state laws; and (v) The individual practitioner complies fully with all other applicable requirements under the Act and these regulations as well as any additional requirements under state law. (2) Nothing in this paragraph (b) shall be construed as mandating or encouraging individual practitioners to issue multiple prescriptions or to see their patients only once every 90 days when prescribing Schedule II controlled substances. Rather, individual practitioners must determine on their own, based on sound medical judgment, and in accordance with established medical standards, whether it is appropriate to issue multiple prescriptions and how often to see their patients when doing so. [72 FR 64929, Nov. 19, 2007]

Schedule II Substances 2) SCHEDULE II.--A substance in Schedule II has a high potential for abuse and has a currently accepted but severely restricted medical use in treatment in the United States, and abuse of the substance may lead to severe psychological or physical dependence. The following substances are controlled in Schedule II: (a) Unless specifically excepted or unless listed in another schedule, any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis: 1. Opium and any salt, compound, derivative, or preparation of opium, except nalmefene or isoquinoline alkaloids of opium, including, but not limited to the following: a. Raw opium. b. Opium extracts. c. Opium fluid extracts. d. Powdered opium. e. Granulated opium. f. Tincture of opium. g. Codeine. h. Ethylmorphine. i. Etorphine hydrochloride. j. Hydrocodone. k. Hydromorphone. l. Levo-alphacetylmethadol (also known as levo-alphaacetylmethadol, levomethadyl acetate, or LAAM).

m. Metopon (methyldihydromorphinone). n. Morphine. o. Oxycodone. p. Oxymorphone. q. Thebaine. 2. Any salt, compound, derivative, or preparation of a substance which is chemically equivalent to or identical with any of the substances referred to in subparagraph 1., except that these substances shall not include the isoquinoline alkaloids of opium. 3. Any part of the plant of the species Papaver somniferum, L. 4. Cocaine or ecgonine, including any of their stereoisomers, and any salt, compound, derivative, or preparation of cocaine or ecgonine. (b) Unless specifically excepted or unless listed in another schedule, any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation: 1. Alfentanil. 2. Alphaprodine. 3. Anileridine. 4. Bezitramide. 5. Bulk propoxyphene (nondosage forms). 6. Carfentanil. 7. Dihydrocodeine. 8. Diphenoxylate. 9. Fentanyl.

10. Isomethadone. 11. Levomethorphan. 12. Levorphanol. 13. Metazocine. 14. Methadone. 15. Methadone-Intermediate,4-cyano-2- dimethylamino-4,4-diphenylbutane. 16. Moramide-Intermediate,2-methyl- 3-morpholoino-1,1-diphenylpropane-carboxylic acid. 17. Nabilone. 18. Pethidine (meperidine). 19. Pethidine-Intermediate-A,4-cyano-1- methyl-4-phenylpiperidine. 20. Pethidine-Intermediate-B,ethyl-4- phenylpiperidine-4-carboxylate. 21. Pethidine-Intermediate-C,1-methyl-4- phenylpiperidine-4- carboxylic acid. 22. Phenazocine. 23. Phencyclidine. 24. 1-Phenylcyclohexylamine. 25. Piminodine. 26. 1-Piperidinocyclohexanecarbonitrile. 27. Racemethorphan. 28. Racemorphan.

29. Sufentanil. (c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including their salts, isomers, optical isomers, salts of their isomers, and salts of their optical isomers: 1. Amobarbital. 2. Amphetamine. 3. Glutethimide. 4. Methamphetamine. 5. Methylphenidate. 6. Pentobarbital. 7. Phenmetrazine. 8. Phenylacetone. 9. Secobarbital.